Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Prog Urol ; 23(1): 50-7, 2013 Jan.
Artículo en Francés | MEDLINE | ID: mdl-23287484

RESUMEN

OBJECTIVE: To compare the perception of benign prostatic hypertrophy (BPH) between patients and general practitioners (GPs) in terms of severity and evolution of symptoms and medication adherence. METHODOLOGY: A cross-sectional observational study was performed in France in a sample of GPs who included patients for whom a BPH treatment was prescribed. Data were collected on patient and GP characteristics, diagnosis, BPH management, severity and evolution of symptoms and medication adherence. RESULTS: One thousand and ninety-eight patients were recruited by 247 GPs. In 87.4% of cases, diagnosis was performed by GPs. Among them, 82.7% of patients were treated by monotherapy. The choice of a treatment was mainly based on treatment efficacy and the patient's opinion was taken into account by 5% of GPs. The patient's evaluation of symptoms severity was consistent with the GP's in 53.9% of cases. A worsening of symptoms was reported significantly more frequently by patients (18.5%) than by GPs (8.8%). Among 94 patients who reported poor adherence, GPs estimated that the level of medication adherence was good for 72 of these (77%). CONCLUSION: There was discordance between the evaluation made by GPs and by patients on the perception of BPH symptoms and medication adherence. The patient's opinion was rarely taken into account in the therapeutic decision, reflecting a lack of shared medical decision-making, which would be helpful for the physician in order to optimize BPH management.


Asunto(s)
Actitud Frente a la Salud , Médicos Generales/psicología , Cumplimiento de la Medicación/psicología , Pacientes/psicología , Hiperplasia Prostática/diagnóstico , Hiperplasia Prostática/psicología , Antagonistas Adrenérgicos alfa/uso terapéutico , Anciano , Anciano de 80 o más Años , Estudios Transversales , Francia , Conocimientos, Actitudes y Práctica en Salud , Humanos , Masculino , Persona de Mediana Edad , Educación del Paciente como Asunto/métodos , Hiperplasia Prostática/tratamiento farmacológico , Calidad de Vida , Factores de Riesgo , Muestreo , Índice de Severidad de la Enfermedad , Encuestas y Cuestionarios , Resultado del Tratamiento
2.
J Fr Ophtalmol ; 36(2): 124-8, 2013 Feb.
Artículo en Francés | MEDLINE | ID: mdl-22981523

RESUMEN

Sectoral choroidal ischemia is a classic sign of giant cell arteritis, although the latter is more typically associated with anterior ischemic optic neuropathy or central retinal artery occlusion. We report the case of an acute choroidal ischemia in a 68-year-old, one-eyed patient, who presented with deterioration of visual acuity and metamorphopsia in his left eye (his right eye was counting fingers due to high myopia). Fundus examination revealed retinal pigment epithelium (RPE) alterations and slow choroidal perfusion on fluorescein angiography. Macular Optical Coherence Tomography (OCT) showed a total disruption of the photoreceptor layer. Although prompt corticosteroid therapy preserved some vision, secondary macular retinal pigment epithelial changes limited the visual outcome. No other ophthalmological signs were observed in follow-up.


Asunto(s)
Enfermedades de la Coroides/diagnóstico , Coroides/irrigación sanguínea , Isquemia/diagnóstico , Enfermedad Aguda , Corticoesteroides/uso terapéutico , Anciano , Enfermedades de la Coroides/tratamiento farmacológico , Enfermedades de la Coroides/etiología , Angiografía con Fluoresceína , Humanos , Isquemia/complicaciones , Isquemia/tratamiento farmacológico , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA